Biotechnology News: Advancements in Technology Augmenting Molecular Cytogenetics Market Growth

Posted on 2019-08-11 by P&S Intelligence in Biotech, Healthcare // 0 Comments

New York, United States, 2019-Aug-11 — /EPR Network/ — The global molecular cytogenetics market accumulated $1.8 billion revenue in 2017, and it is projected to attain a CAGR of 9.9% during the forecast period (2018–2023). The increasing popularity of pharmacogenomics in drug development and personalized disease management, advancements in cytogenetic techniques, and employment of these techniques in detecting chromosomal abnormalities are influencing the market growth. With the growing number of cytogenetic abnormalities, cases of cancer, and drugs becoming redundant in the treatment of diseases, a more robust technique is needed for determining the cause of and managing such conditions.

Molecular cytogenetics is the branch of genetics that deals with the study of chromosomal structure, its location and function within a cell, and the detection of genetic diseases. It utilizes techniques such as comparative genomic hybridization (CGH), fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and karyotyping in various applications of biology and medicine. The market is segmented by technology, application, end-user, geography, and offering. On the basis of technology, the market is subdivided into FISH, IHC, CGH, karyotyping, and others. The market for FISH is expected to grow at a CAGR of 10.1% during the forecast period.

The global molecular cytogenetics market is being driven by a number of factors, one being the rising cases of cancer. Cancer as a disease involves numerous mutations, which are either disease-specific or could vary from one individual to another. Molecular cytogenetics techniques such as single nucleotide polymorphism (SNP), CGH, FISH, and genomic expression profiling are not only helping researchers in identifying cancer-specific biomarkers, but are also helping doctors in providing better diagnosis, prognosis and treatment to patients.

GLOBAL MOLECULAR CYTOGENETICS MARKET SEGMENTATION

Market Segmentation by Offering

Consumables
Software & Services
Instruments

Market Segmentation by Technology

Comparative Genomic Hybridization (CGH)
- Array-based CGH
- Standard CGH
Fluorescence in situ hybridization (FISH)
Immunohistochemistry (IHC)
Karyotyping
- Spectral karyotyping
- Virtual karyotyping

Market Segmentation by Application

Cancer
Genetic Disorders
Personalized Medicine
Others

Market Segmentation by End User

Clinical & Research Laboratories
Academic Research Institutes
Hospitals & Pathology Laboratories
Pharmaceutical & Biotechnology Companies
Others

Market Segmentation by Geography

North America molecular cytogenetics market
Europe Molecular Cytogenetics Market
Asia-Pacific (APAC) Molecular Cytogenetics Market
Latin America (LATAM) Molecular Cytogenetics Market
Middle East & Africa (MEA) Molecular Cytogenetics Market

Request for report sample at: http://bit.ly/2kS1GfJ

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Matched content

Editor’s pick